◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Home › All stocks › B › BPLPHARMA

Bharat Parenterals Limited (BPLPHARMA) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-20

Bharat Parenterals Limited (BPLPHARMA) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Vadodara, India with about 404 employees. In the fiscal year ended 2026-03-31, BPLPHARMA reported ₹3.4B in revenue and (₹82M) in net income.

Bharat Parenterals Limited engages in the research, development, manufacturing, marketing, sourcing, and distribution of pharmaceutical products in India and internationally.

Interactive charts & full statements →

BPLPHARMA Revenue & Earnings History — Annual Income Statement

Income statement2026-03-312025-03-312024-03-312023-03-312022-03-31
Total Revenue₹3.4B₹3.4B₹2.6B₹2.2B—
Gross Profit₹1.4B₹1.2B₹885M₹720M—
Operating Income (EBIT)(₹184M)(₹309M)₹181M₹157M—
Net Income(₹82M)(₹126M)₹145M₹164M—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BPLPHARMA Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-30
Total Revenue₹937M₹996M₹652M₹646M₹1.2B
Gross Profit₹474M₹419M₹329M₹377M₹472M
Operating Income (EBIT)(₹2M)(₹92M)(₹67M)(₹77M)₹52M
Net Income₹10M(₹48M)(₹53M)(₹72M)₹82M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BPLPHARMA Free Cash Flow History

Cash flow2026-03-312025-03-312024-03-312023-03-312022-03-31
Dividends Paid(₹7M)(₹6M)(₹4M)——

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BPLPHARMA Balance Sheet History

Balance sheet2026-03-312025-03-312024-03-312023-03-312022-03-31
Total Assets₹6.1B₹6.5B₹5.0B₹3.5B—
Total Liabilities₹3.0B₹3.1B₹2.7B₹1.3B—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BPLPHARMA viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

← BPLAll “B” companiesBPOP →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.